| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.25▼ | 1.25▼ | 1.25▼ | 1.24▲ | 1.40▼ |
| MA10 | 1.46▼ | 1.46▼ | 1.46▼ | 1.29▼ | 1.53▼ |
| MA20 | 1.67▼ | 1.68▼ | 1.66▼ | 1.49▼ | 1.97▼ |
| MA50 | 1.73▼ | 1.71▼ | 1.73▼ | 1.65▼ | 2.67▼ |
| MA100 | 1.86▼ | 1.96▼ | 2.09▼ | 2.08▼ | N/A |
| MA200 | 2.24▼ | 2.50▼ | 2.65▼ | 3.17▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.066▼ | -0.063▼ | -0.059▼ | -0.018▼ | -0.052▼ |
| RSI | 18.868▼ | 25.615▼ | 27.139▼ | 38.247▼ | 35.785▼ |
| STOCH | 1.131▼ | 1.131▼ | 1.131▼ | 34.475 | 16.129▼ |
| WILL %R | -97.857▼ | -97.857▼ | -97.857▼ | -77.658▼ | -90.135▼ |
| CCI | -82.083 | -82.083 | -82.142 | -67.833 | -134.058▼ |
|
Tuesday, March 24, 2026 06:46 AM
CORRECTING / Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage, oncology-focused biotechnology company, today announced that it has received formal approval ...
|
|
Monday, December 15, 2025 12:08 AM
Silexion Therapeutics is developing RNA interference (RNAi) therapies aimed at KRAS-driven cancers - among the most prevalent and historically difficult-to-treat oncogenic drivers in solid tumors such ...
|
|
Monday, December 15, 2025 12:08 AM
Silexion Therapeutics is developing RNA interference (RNAi) therapies aimed at KRAS-driven cancers - among the most prevalent and historically difficult-to-treat oncogenic drivers in solid tumors such ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 1.245 | 1.245 | 1.245 | 1.245 | 18,164 |
| 31/03/26 | 1.1801 | 1.28 | 1.17 | 1.28 | 47,717 |
| 30/03/26 | 1.215 | 1.2897 | 1.1217 | 1.16 | 14,652 |
| 27/03/26 | 1.3419 | 1.3419 | 1.20 | 1.22 | 25,199 |
| 26/03/26 | 1.42 | 1.42 | 1.275 | 1.31 | 43,576 |
| 25/03/26 | 1.355 | 1.42 | 1.32 | 1.42 | 37,632 |
| 24/03/26 | 1.26 | 1.355 | 1.10 | 1.34 | 216,757 |
| 23/03/26 | 1.27 | 1.31 | 1.23 | 1.27 | 25,016 |
| 20/03/26 | 1.48 | 1.4801 | 1.21 | 1.22 | 62,848 |
| 19/03/26 | 1.50 | 1.50 | 1.3045 | 1.40 | 68,442 |
|
|
||||
|
|
||||
|
|